D.E. Shaw & Co’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $626K | Buy |
+237,147
| New | +$626K | ﹤0.01% | 2440 |
|
|
2024
Q4 | – | Sell |
-520,053
| Closed | -$1.93M | – | 3174 |
|
|
2024
Q3 | $1.93M | Buy |
+520,053
| New | +$1.93M | ﹤0.01% | 1814 |
|
|
2024
Q2 | – | Sell |
-236,634
| Closed | -$1.27M | – | 3307 |
|
|
2024
Q1 | $1.27M | Sell |
236,634
-354,467
| -60% | -$1.9M | ﹤0.01% | 1988 |
|
|
2023
Q4 | $2.97M | Buy |
+591,101
| New | +$2.97M | ﹤0.01% | 1519 |
|
|
2022
Q4 | – | Sell |
-678,504
| Closed | -$3.37M | – | 3686 |
|
|
2022
Q3 | $3.37M | Buy |
678,504
+267,827
| +65% | +$1.33M | ﹤0.01% | 1764 |
|
|
2022
Q2 | $1.53M | Buy |
410,677
+315,409
| +331% | +$1.17M | ﹤0.01% | 2442 |
|
|
2022
Q1 | $534K | Sell |
95,268
-235,233
| -71% | -$1.32M | ﹤0.01% | 3180 |
|
|
2021
Q4 | $2.01M | Sell |
330,501
-46,969
| -12% | -$286K | ﹤0.01% | 2376 |
|
|
2021
Q3 | $3.68M | Buy |
377,470
+293,098
| +347% | +$2.86M | ﹤0.01% | 1690 |
|
|
2021
Q2 | $1.21M | Buy |
+84,372
| New | +$1.21M | ﹤0.01% | 2387 |
|
|
2020
Q4 | – | Sell |
-42,661
| Closed | -$296K | – | 2793 |
|
|
2020
Q3 | $296K | Buy |
+42,661
| New | +$296K | ﹤0.01% | 2278 |
|
|
2019
Q3 | – | Sell |
-13,200
| Closed | -$13K | – | 2643 |
|
|
2019
Q2 | $13K | Sell |
13,200
-1,508
| -10% | -$1.49K | ﹤0.01% | 2559 |
|
|
2019
Q1 | $23K | Sell |
14,708
-165,887
| -92% | -$259K | ﹤0.01% | 2501 |
|
|
2018
Q4 | $210K | Buy |
180,595
+139,431
| +339% | +$162K | ﹤0.01% | 2364 |
|
|
2018
Q3 | $152K | Sell |
41,164
-15,432
| -27% | -$57K | ﹤0.01% | 2410 |
|
|
2018
Q2 | $174K | Buy |
56,596
+15,787
| +39% | +$48.5K | ﹤0.01% | 2462 |
|
|
2018
Q1 | $159K | Buy |
40,809
+28,781
| +239% | +$112K | ﹤0.01% | 2399 |
|
|
2017
Q4 | $54K | Buy |
+12,028
| New | +$54K | ﹤0.01% | 2479 |
|